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http://www.biomedcentral.com/1471-2261/14/41RESEARCH ARTICLE Open AccessIntermittent short ECG recording is more effective
than 24-hour Holter ECG in detection of
arrhythmias
Tijn Hendrikx1*, Mårten Rosenqvist2, Per Wester3, Herbert Sandström1 and Rolf Hörnsten4Abstract
Background: Many patients report symptoms of palpitations or dizziness/presyncope. These patients are often
referred for 24-hour Holter ECG, although the sensitivity for detecting relevant arrhythmias is comparatively low.
Intermittent short ECG recording over a longer time period might be a convenient and more sensitive alternative.
The objective of this study is to compare the efficacy of 24-hour Holter ECG with intermittent short ECG recording
over four weeks to detect relevant arrhythmias in patients with palpitations or dizziness/presyncope.
Methods: Design: prospective, observational, cross-sectional study. Setting: Clinical Physiology, University Hospital.
Patients: 108 consecutive patients referred for ambiguous palpitations or dizziness/presyncope. Interventions: All
individuals underwent a 24-hour Holter ECG and additionally registered 30-second handheld ECG (Zenicor EKG®
thumb) recordings at home, twice daily and when having cardiac symptoms, during 28 days. Main outcome
measures: Significant arrhythmias: atrial fibrillation (AF), paroxysmal supraventricular tachycardia (PSVT),
atrioventricular (AV) block II–III, sinus arrest (SA), wide complex tachycardia (WCT).
Results: 95 patients, 42 men and 53 women with a mean age of 54.1 years, completed registrations. Analysis of
Holter registrations showed atrial fibrillation (AF) in two patients and atrioventricular (AV) block II in one patient
(= 3.2% relevant arrhythmias [95% CI 1.1–8.9]). Intermittent handheld ECG detected nine patients with AF, three
with paroxysmal supraventricular tachycardia (PSVT) and one with AV-block-II (= 13.7% relevant arrhythmias [95% CI
8.2–22.0]). There was a significant difference between the two methods in favour of intermittent ECG with regard to
the ability to detect relevant arrhythmias (P = 0.0094). With Holter ECG, no symptoms were registered during any of
the detected arrhythmias. With intermittent ECG, symptoms were registered during half of the arrhythmia episodes.
Conclusions: Intermittent short ECG recording during four weeks is more effective in detecting AF and PSVT in
patients with ambiguous symptoms arousing suspicions of arrhythmia than 24-hour Holter ECG.
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Many patients report symptoms of palpitations and diz-
ziness/presyncope. These patients are often referred for
24-hour Holter ECG, although the sensitivity of this in-
vestigation for detecting relevant arrhythmias is com-
paratively low as symptoms in general are transitory,
and the patients often are asymptomatic during the in-
vestigation [1-4].* Correspondence: tijn.hendrikx@fammed.umu.se
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unless otherwise stated.Patient-operated intermittent ECG recordings could
potentially improve the diagnosis of transitory ECG
changes in such patients and may give results compar-
able to standard external loop event recorders [5,6]. The
advantage of such devices compared to standard external
loop event recorders is that they are reasonably priced
and easy to use, especially as no external electrodes are
necessary.
Even when using (handheld or standard external loop)
event recorders, episodes of an arrhythmia may be missed
as the correlation between symptoms and relevant arrhyth-
mias is often not very strong. In atrial fibrillation (AF), foral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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symptomatic [7]. The European Heart Rhythm Association
stated in a 2011 position paper on palpitations that it is es-
pecially important to exclude AF as the underlying cause of
symptoms in patients with palpitations of unknown origin,
as AF is associated with an increased risk of thrombo-
embolism [8-10]. Recent studies show that intermittent
ECG recording with both regular and symptomatic regis-
trations detects more episodes of silent AF in patients with
known paroxysmal atrial fibrillation compared with 24-
hour Holter ECG [11] and improves the detection of previ-
ously unknown asymptomatic paroxysmal atrial fibrillation
(AF) in post-stroke patients [12].
The objective of this study is to compare the efficacy
of short intermittent ECG registrations with 24-hour
Holter ECG, in detecting relevant arrhythmias in pa-
tients reporting symptoms of palpitations and dizziness/
presyncope.
Methods
Design, study population and setting
In this prospective, observational, cross-sectional study 108
consecutive patients with symptoms of ambiguous palpita-
tions or dizziness/presyncope, referred to the Department ofFigure 1 Study flowchart.Clinical Physiology, Norrland University Hospital, Umeå, for
24-hour Holter ECG, were included. (Flowchart, Figure 1).
The catchment area in the present study was the county
of Västerbotten (population 212 660). The Department of
Clinical Physiology is the only centre in Västerbotten
County for this type of service. Palpitations were defined as
a sensation in which a person is aware of an irregular, hard
or rapid heartbeat. Dizziness/presyncope was defined as a
sensation in which a person experiences light-headedness,
unsteadiness or near-fainting. Exclusion criteria were:
known arrhythmia, based on previous history or 12-lead
ECG performed at the time of referral; referral for syncope,
defined as temporary loss of consciousness; or comorbidity
with cognitive or other functional impairments impeding
the use of the handheld device. Of 108 patients 84 were re-
ferred by a primary health care centre and 24 by a hospital
clinic. The study complies with the Declaration of Helsinki
and was approved by the Regional Ethical Review Board,
Umeå (Dnr 07-051M). All participating patients gave writ-
ten informed consent.
Intervention
Holter recordings were performed using a standard re-
cording unit (Breamer DL700, Breamer Inc. Burnsville,
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by a PC-based Holter system (Aspect Holter System, GE
Healthcare, Stockholm, Sweden).
Patients were asked to additionally perform 30-second
intermittent handheld ECG (Zenicor EKG® thumb,
Stockholm, Sweden) registrations at home for 28 days,
twice daily, morning and evening, and when having car-
diac symptoms, resulting in a total registration time of
approximately half an hour. Intermittent recordings
started on the same day as the 24-hour Holter ECG
recording.
Handheld ECG registrations and Holter registrations
were evaluated separately by two investigators with expert-
ise in arrhythmology who were blinded to the result of the
other method. In case of diagnostic uncertainty, a consen-
sus was reached by the two investigators together with a
cardiologist.
The handheld device
Zenicor EKG® thumb is a handheld device which via both
thumbs registers a bipolar extremity lead I ECG for 30 sec-
onds. After each registration the recording is transmitted
by the patient via the built-in mobile device (SIM card) to a
web-based central database. Symptomatic episodes can be
marked with a button. In the database these symptomatic
registrations are highlighted. The ability to give the correct
diagnosis of AF compared to 12-lead ECG has shown a
sensitivity of 96% and a specificity of 92% [13]. A detailed
technical description of the device and its performance is
published elsewhere [13].
Information on age; sex; smoking; earlier cardiac ultra-
sound, carotid doppler and ECG; CHA2DS2-VASc risk
factors; amount and duration of earlier episodes of palpi-
tations and the presence of dizziness was collected in a
Case Report Form (CRF) in the web-based central
database.
Outcome measures
Significant arrhythmias were defined as: atrial fibrillation
(AF) ≥30 seconds and AF defined as irregular heart
rhythm without distinct sinus p-waves; paroxysmal sup-
raventricular tachycardia (PSVT) ≥30 seconds, defined
as regular rhythm, with supraventricular extrasystoles
(SVES) in series, >120 beats/minute; atrioventricular
(AV) block II–III; sinus arrest (SA) >2.5 seconds; wide
complex tachycardia (WCT) with a QRS width of >120
ms and with a heart rate >100 beats/minute and at least
3 wide QRS complexes after each other. Patients with
detected arrhythmias were referred for treatment in ac-
cordance with national guidelines.
Statistics
Continuous variables were presented with median and
interquartile range (IQR), except for age and heart ratewhich were presented with mean, standard deviation (SD)
and range. Categorical variables were presented with count
and percentage and, where appropriate, a 95% confidence
interval. To test the hypothesis that there is a statistical dif-
ference in the efficacy of intermittent ECG recordings com-
pared to 24-hour continuous Holter monitoring in
detecting relevant arrhythmias, we used McNemar’s test for
paired proportions. To evaluate possible differences in age,
the number of registrations and the amount and duration
of previous episodes with palpitations between individuals
with and without detected AF, the Mann-Whitney U test
was used. To evaluate the relation between history of palpi-
tations, sex and CHA2DS2-VASc categories and the detec-
tion of AF, the Pearson Chi-square test was used. SPSS
Statistics 19.0 (IBM Corporation, Route 100 Somer, NY
10589) was used for all calculations. The level of signifi-
cance was set at 0.05, two-sided. The study was dimen-
sioned to detect clinically relevant discrepancies between
the two methods based on the following population effect
size: in 80% of the patients, both methods will classify a pa-
tient as negative for a relevant arrhythmia and in another
3% both methods will classify a patient as positive. A dis-
crepancy between the methods was assumed in the popula-
tion as follows: in 14% of all patients only one test will
show an outcome of positive relevant arrhythmia, while 3%
of all patients will show an outcome of positive relevant
arrhythmia for the other method. We needed 90 patients to
yield a power of 80% with a statistically significant result
with alpha of 0.05 (two-tailed). Calculating with a drop-out
rate of 15% 106 patients needed to be included; the power
calculation was performed in SamplePower 2.0.
Results
Demographics
Ninety-five patients, 42 men and 53 women with a mean
age of 54.1 years, completed registrations. Thirteen of
the originally included 108 patients were excluded
after initial inappropriate inclusion; they either had a
known tachyarrhythmia (n = 8) or suffered from syncope
(n = 5). (Flowchart, Figure 1. Demographic data, Table 1).
Of these 95 patients, 80 were referred for palpitations and
15 for dizziness/presyncope. 77 patients were referred by a
primary health care centre and 18 by a hospital clinic.
All patients were able to perform intermittent regis-
trations. The median number of intermittent ECG
registrations was 59 with and interquartile range
(IQR) of 48.5– 65. Seventy-one patients (74.7%) com-
pleted at least 50 registrations and only eight patients
(8.4%) made less than 28 registrations, i.e., half of the
stipulated 56 registrations. Holter patients completed
their 24-hour recording with the exception of one pa-
tient who recorded only 11 hours and eight minutes.
Both handheld and Holter registrations were of good
quality. Only 1.6% of handheld registrations (84 of 5229
Table 1 Demographic characteristics of the study
population
Demographic characteristics
Total population [n] 95
Men [n, (%)] 42 (44.2)
Age [years, mean, SD, (range)] 54.1 ±16.4 (21–79)
Primary care referral [n, (%)] 77 (81.1)
Smoking [n, (%)] 7 (7.4)
Earlier palpitations, [n, (%)] 80 (84.2)
Dizziness/presyncope [n, (%)] 15 (15.8)
Congestive Heart Failure [n, (%)] 0
Hypertension [n, (%)] 27 (28.4)
Age ≥65 < 75 [n, (%)] 30 (31.6)
Age ≥75 [n, (%)] 9 (9.5)
Diabetes [n, (%)] 1 (1.1)
Earlier stroke/TIA/TE [n, (%)] 6 (6.3)
Cardiovascular disease [n, (%)] 8 (8.4)
CHA2DS2-VASc = 0 [n, (%)] 19 (20)
CHA2DS2-VASc = 1 [n, (%)] 45 (47.4)
CHA2DS2-VASc≥ 2 [n, (%)] 31 (32.6)
Palpitation episodes last year [n, median, (IQR)] 110 (27.3–176.3)
Duration palpitation episodes last year [min,
median, (IQR)]
10 (3.5–30)
Patients with symptoms during intermittent ECG
[n, (%)]
31 (32.6)
Patients with symptoms during 24-hour Holter
[n, (%)]
40 (42.1)
Intermittent registrations, total [n, median, (IQR)] 59 (48.5–65)
Intermittent registrations with symptoms [n,
median, (IQR)]
3 (0–9)
Intermittent registrations with analysable tracing
quality [n, median, (IQR)]
57 (45.5–65)
24-hour Holter registration time with analysable
quality of tracing [h.min, median, (IQR)]
24.00 (23.55–24.00)
IQR = interquartile range; SD = standard deviation; TE = thrombo-embolism;
TIA = transient ischemic attack.
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2280 hours) were of non-analysable quality.
Previously experienced palpitations
The characteristics of palpitations experienced within
the last 12 months before performing the ECG investiga-
tions are presented in Table 1 and 2. No data on the
number of episodes of dizziness/presyncope and dur-
ation of these episodes were included.
Detection of relevant arrhythmias
Analysis of the 24-hour Holter recordings showed AF in
two patients and AV-block II in one patient. This resulted
in a total of 3.2% relevant arrhythmias [95% CI 1.1–8.9]
detected. Nine patients with AF were detected withintermittent ECG. Two of these were the same as those
discovered with Holter ECG; one of them had persistent
AF. Two AF patients also had episodes with a fast regu-
lar rhythm, either atrial flutter or PSVT. Three patients
were diagnosed with PSVT and one patient with AV-block
II. One additional patient who continued with registra-
tions on his own initiative after day 28 had an AF epi-
sode at day 50. As this was not detected within 28 days
he was not counted as newly diagnosed AF within the
study framework. In total 13.7% relevant arrhythmias
[95% CI 8.2–22.0] were detected with intermittent hand-
held ECG. (Detected arrhythmias, Table 3). The statistical
analysis showed a significant difference between the
two methods in favour of intermittent handheld ECG
recordings with regard to the ability to detect relevant
arrhythmias (P = 0.0094).
All arrhythmia episodes during Holter were asymp-
tomatic. Forty-four percent of all arrhythmia episodes
with intermittent recording were asymptomatic.
Atrial fibrillation
With nine AF patients detected with intermittent hand-
held ECG AF was the main arrhythmia recorded. (An
example of a handheld ECG registration of AF is pro-
vided in Figure 2). One AF patient was found on day
one and the last AF patient was found day 26. Two AF
patients, one of them with persistent AF, were the same
as those discovered with Holter ECG. Patients with AF
were slightly older and had slightly higher CHA2DS2-
VASc scores compared to those without AF, but these
differences were not statistically significant. No statisti-
cally significant differences for previous palpitations
were observed between the AF and non-AF group.
(Characteristics of patients with AF, Table 2). Out of a
total of 61 intermittent registrations (median) for AF pa-
tients (Mean 62; SD ±17.80; Range 48-89) nine (median)
were symptomatic (9/61 = 14.8%). (Table 2). (Mean 7.33;
SD ±5.23; Range 0-16). These patients had four registra-
tions (median) that showed AF, (4/61 = 6.6%). (Table 2).
(Mean 9.33; SD ±18.34; Range 1-61) All AF patients had
a CHA2DS2-VASc of one or more and were therefore
potential candidates for oral anticoagulation treatment.
Paroxysmal supraventricular tachycardia
PSVT was detected in three patients with handheld ECG
with a mean heart rate of 177 bpm (SD ± 18.8, range
154–200). In two patients at least one episode was
symptomatic. (An example of a handheld ECG registra-
tion of PSVT is provided in Figure 2).
Atrioventricular-block II
One patient with AV-block II, discovered with Holter,
was referred for Holter because of palpitations, the
other, discovered with intermittent ECG, because of
Table 2 Demographic and intermittent ECG characteristics of patients with and without AF
Demographic characteristics AF Non AF P-Value
Patients [n, (%)] 9 (9.5) 86 (90.5)
Men [n, (%)] 3 (33.3) 39 (45.3) 0.490
Age [years, mean, SD, (range)] 58.3 ±11.5 (28–67) 53.8 ±16.8 (21–79) 0.476
Referred for palpitations [n, (%)] 9 (100) 71 (82.6) 0.172
CHA2DS2-VASc = 0 [n, (%)] 0 19 (22.1) 0.115
CHA2DS2-VASc = 1 [n, (%)] 5 (55.6) 40 (46.5) 0.605
CHA2DS2-VASc≥ 2 [n, (%)] 4 (44.4) 27 (31.4) 0.427
Palpitation episodes last year [n, median (IQR)] 110 (105–115) 110 (25.8–178.8) 0.969
Duration of palpitation episodes [min, median (IQR)] 10 4.3–26.3 10 3.5–30 0.979
Intermittent ECG characteristics AF Non AF P-Value
Time to detection [n, (%)] Day 1 1 (11.1)
Day 2–14 5 (55.6)
Day 15–28 3 (33.3)
Heart rate AF [bpm, mean, SD, (range)] 145 ±19.0 (120–184)
Registrations, total [n, median (IQR)] 61 (58–70) 57.5 (46.8–64.8) 0.234
Registrations with symptoms [n, median (IQR)] 9 (2–9) 2.5 (0–8.8) 0.216
Registrations with analysable tracing quality [n, median (IQR)] 61 (54–70) 57 (45–64.8) 0.247
Intermittent registrations with AF [n, median (IQR)] 4 (1–5)
Symptomatic AF registrations [n, median (IQR)] 2 (0–3)
AF = atrial fibrillation; IQR = interquartile range; SD = standard deviation.
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toms related to the recorded arrhythmia.
Discussion
Results
The main finding of this study is that intermittent ECG
recording is superior to routine 24-hour Holter ECG in
detecting relevant paroxysmal arrhythmias in a patient
population reporting symptoms of palpitations, dizzi-
ness/presyncope. The novelty in this study compared to
other studies searching for paroxysmal arrhythmias is
the use of prolonged intermittent recording for four
weeks, both regularly twice daily and when having symp-
toms. To our knowledge, there are no earlier reports
comparing brief intermittent long-term ECG with 24-
hour Holter ECG in detecting paroxysmal arrhythmias
in patients referred for ambiguous cardiac symptoms.Table 3 Detection of relevant arrhythmias – 24-hour







24-hour Holter ECG positive 2 1 3*
24-hour Holter ECG negative 11 81 92
Added results 13† 82 Total: 95
*24-hour Holter ECG added results. n = 3, 3.2%, [95% CI 1.1–8.9].
†Intermittent ECG added results. n = 13, 13.7%, [95% CI 8.2–22.0].It was already known that the sensitivity of 24-hour
Holter recordings for detecting relevant arrhythmias is
low but it is still widely used as a routine in primary care
and hospital settings. The fact that almost half of the
intermittent recordings showing significant arrhythmias
were recorded without associated symptoms emphasizes
that this method has advantages compared to standard
Event recording.
At the same time it should be mentioned that it has
been previously estimated that only one in ten parox-
ysms of AF is symptomatic [7,14]. The much higher rate,
about fifty percent, of symptomatic episodes in this
study may be explained by the fact that included patients
are selected for having ambiguous cardiac symptoms.
Relevance
The two main arrhythmias detected in this study were
AF and PSVT. Occurrence of AF constitutes in itself an
independent risk factor for stroke, and with concurrent
other risk factors (congestive heart disease, hypertension,
age ≥65 years, age ≥75 years, diabetes, earlier stroke/
transient ischemic attack (TIA)/thrombo-embolism
(TE), vascular disease and female sex (CHA2DS2-VASc)),
this risk is additionally increased [8,15]. It is extremely
important to detect and treat AF patients before they
suffer a stroke. As stroke risk is the same for symptom-
atic and non-symptomatic AF patients, [16] this method
Figure 2 Example of handheld ECG registration of AF and PSVT.
Hendrikx et al. BMC Cardiovascular Disorders 2014, 14:41 Page 6 of 8
http://www.biomedcentral.com/1471-2261/14/41could also be warranted for screening of asymptomatic
patients with higher CHA2DS2-VASc scores [17-19].
Detection of PSVT is relevant as it can be caused by
re-entry tachycardias, potentially curable with ablation.
Previous studies have also shown that PSVT patients
have a higher risk of developing atrial fibrillation [20]
and flutter [21].
The study population consisted of relatively young and
healthy patients of whom the majority were referred from
Primary Care. However, the fact that all AF patients had
a CHA2DS2-VASc score ≥ 1 indicates that most of thesepatients could be candidates for oral anticoagulation
(OAC) treatment. (Table 2).
Device and recording protocol
The device is small and seldom limits the mobility of the
patients. Registrations are easy to perform. The chosen
method gives the possibility for both asymptomatic and
symptomatic registrations and allows registration over a
long time period, which seems to be important as only
two thirds of the recorded arrhythmias occurred within
14 days. (Figure 3, Table 2). An advantage compared to
Figure 3 Time to detection (days) of relevant arrhythmias (AF, PSVT and AV-block II) with intermittent handheld ECG recording.
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is transmitted by the patient via the built-in mobile de-
vice (SIM card) directly to a web-based central database
and can be analysed online.
Compliance
Compliance with the intermittent handheld ECG method
was high. The 95 included patients had a median of 59
registrations (IQR 48.5–65), which is more than two regis-
trations a day for 28 days. The high compliance rate using
this method indicates that it is a feasible method for
screening in larger patient populations.
Limitations
With the handheld device no registrations are made
during physical exertion, sleep or syncope. Other de-
vices, e.g. patch-based appliances with the possibility
of long-term continuous recording, are most likely an
even better alternative than devices for short intermit-
tent recording, as these would not miss episodes dur-
ing physical exertion, sleep, or syncope [22]. Smart
phone based applications can, in the light of their high
accessibility, also be expected to become useful tools
for screening and monitoring of AF and other paroxys-
mal arrhythmias [23-25].
The handheld device only records lead I, which some-
times makes it difficult to distinguish atrial flutter from
sinus rhythm or a regular supraventricular tachycardia. This
might have resulted in underdetection of atrial flutter [13].
Registrations are only 30 seconds. If there is an
arrhythmia like AF only at the beginning or at the end
of the registration we cannot be certain of how long this
episode actually lasted. The AF definition used by the
European Society of Cardiology in its Guidelines from
2010: ‘Any arrhythmia that has the ECG characteristics
of AF and lasts sufficiently long for a 12-lead ECG to berecorded, or at least 30 s on a rhythm strip, should be
considered as AF’, is based on consensus and the clinical
implication for risk of stroke is as yet not fully under-
stood [26].
Generalizability
All patients referred to the Department of Clinical
Physiology for ambiguous palpitations or dizziness/
presyncope were included consecutively. Except for known
arrhythmia, referral for syncope, or comorbidity with cog-
nitive or other functional impairments impeding the
use of the handheld device, no other exclusions were
made. The Department of Clinical Physiology is the
only clinic that performs Holter ECG in the province of
Västerbotten, Northern Sweden therefore selection bias is
limited. Other studies investigating palpitations looking at
a general population show quite similar characteristics for
age, sex and comorbidity [1,10,27,28].
Conclusions
Short intermittent ECG recording, at regular time inter-
vals and when having symptoms, during a four-week
period, is more effective than routine 24-hour Holter
ECG in detecting AF and PSVT in patients with palpita-
tions. The fact that half of the AF episodes were asymp-
tomatic implies that even Event recording has its
limitations in this patient category.
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